Benchmark Electronics (BHE) Q3 2024 earnings summary
Event summary combining transcript, slides, and related documents.
Q3 2024 earnings summary
8 Jul, 2026Executive summary
Q3 2024 revenue was $658 million, exceeding guidance midpoint, with strong Semi-Cap and A&D growth offset by declines in Medical and AC&C sectors; net income was $15.4 million and operating income $28.1 million.
Non-GAAP gross margin reached 10.2% (up 50 bps YoY), and non-GAAP operating margin was 5.3%, marking the 16th consecutive quarter of YoY expansion.
Free cash flow for Q3 was $29 million, with trailing 12-month free cash flow totaling $245 million; operating cash flow for Q3 was $39 million.
Inventory reduced by $18 million sequentially and $143 million year-over-year, supporting cash flow and working capital efficiency.
International sales comprised 65% of Q3 2024 revenue, up from 60% in Q3 2023.
Financial highlights
Q3 non-GAAP EPS was $0.57, at the high end of guidance; GAAP EPS was $0.42, both down year-over-year.
GAAP gross margin was 10.1%, non-GAAP gross margin 10.2%; GAAP operating margin 4.3%, non-GAAP 5.3%.
Cash balance at quarter-end was $324 million, up from $283 million at year-end 2023.
Net cash positive position of $46 million at quarter end.
ROIC improved to 9.9% non-GAAP, up 50-60 bps YoY.
Outlook and guidance
Q4 2024 revenue expected between $640 million and $680 million.
Non-GAAP gross margin guidance at 10.2%; operating margin 4.9%–5.1%.
Non-GAAP EPS guidance for Q4 is $0.53–$0.59; GAAP EPS $0.40–$0.46.
Free cash flow for the year expected to exceed $130 million.
Management expects $60M–$70M in capital expenditures over the next 12 months, mainly for machinery and equipment.
Latest events from Benchmark Electronics
- Margin and cash flow outperformance driven by sector focus, efficiency, and global positioning.BHE
Sidoti September Small-Cap Virtual Conference8 Jul 2026 - Margin expansion and strong free cash flow offset revenue softness, led by Semi-Cap and A&D.BHE
Q4 20248 Jul 2026 - Aerospace, defense, and semi-cap drive growth as global investments and margin expansion continue.BHE
Raymond James 2024 TMT & Consumer Conference8 Jul 2026 - Q1 2026 revenue up 7% to $677M, outlook raised on strong Medical, AC&C, and Semi-Cap growth.BHE
Q1 202630 Apr 2026 - Leadership transition, sector growth, and strong financials position for future expansion.BHE
28th Annual Needham Growth Conference Virtual21 Apr 2026 - Q4 2025 delivered strong revenue and EPS growth, with robust cash flow and a positive 2026 outlook.BHE
Q4 202520 Apr 2026 - Directors, executive pay, auditor ratification, and incentive plan share increase up for vote.BHE
Proxy filing17 Apr 2026 - Annual meeting covers director elections, executive pay, auditor ratification, and equity plan amendment.BHE
Proxy filing17 Apr 2026 - Growth driven by Semi-Cap, AI, and medical sectors, with strong margins and disciplined capital use.BHE
Sidoti March Small-Cap Virtual Conference19 Mar 2026